![Jeff Fellows](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Jeff Fellows currently works at Filament Health Corp., as Head-Regulatory.
Mr. Fellows also formerly worked at Mineralys Therapeutics, Inc., as Senior Vice President-Regulatory Affairs from 2023 to 2025 and CTI BioPharma Corp., as Vice President-Regulatory Affairs.
Mr. Fellows received his undergraduate degree from Oregon State University.
Actieve functies van Jeff Fellows
| Bedrijven | Functie | Begin |
|---|---|---|
| FILAMENT HEALTH CORP. | Algemeen Adviseur | - |
Eerdere bekende functies van Jeff Fellows
| Bedrijven | Functie | Einde |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Algemeen Adviseur | 01-07-2025 |
| CTI BIOPHARMA CORP. | Algemeen Adviseur | - |
Opleiding van Jeff Fellows
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Oregon State University
 Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Filament Health Corp.
 Filament Health Corp. Pharmaceuticals: OtherHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
Kies MarketScreener 
